- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00334503
Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
October 8, 2008 updated by: Sanwa Kagaku Kenkyusho Co., Ltd.
The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.
Study Overview
Study Type
Interventional
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aichi, Japan
-
Chiba, Japan
-
Fukuoka, Japan
-
Gunma, Japan
-
Hokkaido, Japan
-
Ibaragi, Japan
-
Kagoshima, Japan
-
Kanagawa, Japan
-
Kumamoto, Japan
-
Miyazaki, Japan
-
Oita, Japan
-
Osaka, Japan
-
Saitama, Japan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 69 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Type 2 diabetic patients with Biguanide treatment
- Criteria for postprandial plasma glucose and HbA1c are met
Exclusion Criteria:
- Type 1 diabetes
- Patients treated with other antidiabetic drugs or Insulin
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
June 5, 2006
First Submitted That Met QC Criteria
June 5, 2006
First Posted (Estimate)
June 7, 2006
Study Record Updates
Last Update Posted (Estimate)
October 10, 2008
Last Update Submitted That Met QC Criteria
October 8, 2008
Last Verified
October 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MG1009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
AstraZenecaRecruiting
Clinical Trials on Miglitol
-
Sanwa Kagaku Kenkyusho Co., Ltd.Completed
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 2 Diabetes MellitusJapan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 2 Diabetes MellitusJapan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 2 Diabetes MellitusJapan
-
Sanwa Kagaku Kenkyusho Co., Ltd.CompletedType 1 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Suez Canal UniversityUnknown
-
Maastricht University Medical CenterCompletedPreeclampsia | HELLP Syndrome | Small for Gestational Age at DeliveryNetherlands
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...Completed